IDEX Q1 sales rise 2% to $814.3 million; diluted EPS falls 21%, full-year guidance kept
IDEX reported first-quarter 2025 net sales of $814.3 million, up 2% from a year earlier but down 1% organically, while GAAP diluted EPS fell to $1.26 from $1.60. The company kept its full-year 2025 organic sales and diluted EPS guidance ranges and added $20 million of cost containment to offset potential tariff-related volume pressure, which matters to shareholders because profit fell even as reported sales grew.
Key points
- Net sales were $814.3 million, up 2% reported and down 1% organically; the Mott acquisition drove the reported increase.
- GAAP diluted EPS was $1.26 versus $1.60; adjusted diluted EPS was $1.75 versus $1.88.
- Orders were a record $871.9 million, up 6% reported and 1% organically.
- Full-year 2025 GAAP diluted EPS guidance is $6.56 to $6.95, unchanged; second-quarter guidance is $1.60 to $1.72.
The filing
Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 01, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.